Volume dodolan mangsa ngarep perusahaan: TransCode (RNAZ)
TransCode Therapeutics specializes in developing DNA-based cancer therapies. The company's sales expectations demonstrate market potential, where the value of 0.00 indicates the current magnitude. The firm relies on high-precision RNA platforms, automates genetic analysis using robotics, and efficiently delegates clinical trials to external contractors to reduce internal costs.
Ringkesan rincian data analitis TransCode (RNAZ)
- kuotasi lan prakiraan analis:
- indikator kapitalisasi bursa perusahaan:
- statistik nilai buku emiten:
- indikator beban utang lan likuiditas:
Total Utang marang Modal TransCode Therapeutics|RNAZ - Kewajiban jangka dawa marang modal|Utang jangka cendhak marang ekuitas TransCode Therapeutics|RNAZ - Kewajiban utang agregat|Utang-utang marang kapitalisasi buku TransCode Therapeutics Inc.|RNAZ - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan TransCode Therapeutics|Rasio cepet transcodetherapeutics.com
- rincian asil keuangan lan kelipatan valuasi:
RNAZ - Penghasilan resik perusahaan|Bathi mangsa ngarep TransCode Therapeutics|RNAZ - Pangali P/E|Prakiraan rega marang bathi TransCode Therapeutics|RNAZ - Rasio nilai perusahaan marang wutah bathi|Pangali EV/EBITDA TransCode Therapeutics Inc.|RNAZ - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi resik saben saham (EPS TTM) TransCode Therapeutics|RNAZ - Bathi resik saben saham sajrone 12 wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan transcodetherapeutics.com|RNAZ - Prakiraan wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi resik saben saham kanggo taun ngarep TransCode Therapeutics
- statistik dodolan lan pendapatan perusahaan:
Pambiji fundamental:TransCode Therapeutics, Inc.
The calculation formula for this indicator is based on the correlation between operating cash flows and projected revenues. This metric determines the market value of the asset by assessing its resilience to volatility and the risk of deep drawdowns. For TransCode Therapeutics (RNAZ), such calculations are critical due to sanction barriers regarding the exchange of genetic data. Geopolitical restrictions on reagents directly compress the potential of future contracts. By analyzing the trend of the firm's sales performance, an investor can discern the business's actual margin of safety.
Analisis perusahaan pesaing
Prakiraan volume dodolan TEM|QGEN - Volume dodolan sing dikarepake perusahaan|Ionis - Volume dodolan mangsa ngarep perusahaan|Pendapatan mangsa ngarep perusahaan RGEN|RNA: Volume dodolan mangsa ngarep perusahaan|CRISPR - Prakiraan volume pendapatan perusahaan|WGS: Prakiraan volume dodolan|ultragenyx.com - Pendapatan mangsa ngarep perusahaan|BEAM (Beam Therapeutics) - Prakiraan volume dodolan|Volume dodolan sing dikarepake perusahaan Sarepta Therapeutics SRPT|Prakiraan pendapatan perusahaan Twist Bio (TWST)|TXG (10x) - Pendapatan mangsa ngarep perusahaan|Prakiraan volume dodolan NTLA (Intellia Therapeutics)|Prakiraan volume dodolan stoketherapeutics.com STOK|BLFS - Prakiraan pendapatan perusahaan|Pendapatan sing dikarepake perusahaan WVE|MAZE: Prakiraan volume dodolan|Volume dodolan sing dikarepake perusahaan Sionna Corp (SION)|Volume dodolan mangsa ngarep perusahaan PRME|Prakiraan volume dodolan tayshagtx.com|Volume dodolan mangsa ngarep perusahaan QURE (uniQure)|Prakiraan volume pendapatan perusahaan MGTX|Prakiraan volume dodolan RGNX (Regenxbio)|Dodolan mangsa ngarep perusahaan Solid Corp (SLDB)|Ocugen, Inc. - Prakiraan volume dodolan|pacb.com (PACB) - Volume dodolan mangsa ngarep perusahaan|Benitec Biopharma (BNTC) - Prakiraan pendapatan perusahaan|DSGN - Dodolan mangsa ngarep perusahaan|Prakiraan pendapatan perusahaan Rocket Pharmaceuticals Inc|FDMT: Pendapatan mangsa ngarep perusahaan|Prakiraan pendapatan perusahaan Lexeo Therapeutics (LXEO)|korrobio.com - Prakiraan pendapatan perusahaan|Prakiraan volume dodolan EDIT (Editas Medicine)|Prakiraan volume dodolan Silence Therapeutics PLC SLN|PRQR: Volume dodolan mangsa ngarep perusahaan|Pendapatan sing dikarepake perusahaan CDXS|SGMO: Prakiraan volume dodolan|Prakiraan pendapatan perusahaan NAUT|Prakiraan pendapatan perusahaan Metagenomi|Prakiraan pendapatan perusahaan DTIL (precisionbiosciences.com)|Prakiraan volume dodolan GBIO|Prakiraan volume dodolan Boundless Bio Inc (BOLD)|Exicure - Volume dodolan mangsa ngarep perusahaan|Prakiraan volume pendapatan perusahaan IMNN (Imunon Inc)|PHIO - Prakiraan pendapatan perusahaan|Pendapatan mangsa ngarep perusahaan MBIO (Mustang Bio, Inc.)|BNGO: Prakiraan volume dodolan|Applied DNA Corp (APDN) - Prakiraan volume dodolan|Prakiraan pendapatan perusahaan bluebird bio, Inc.|Prakiraan pendapatan perusahaan IPA (ImmunoPrecise)|Prakiraan pendapatan perusahaan Omega Therapeutics, Inc. (OMGA)|Dodolan mangsa ngarep perusahaan Singular Genomics Systems, Inc.|Prakiraan volume dodolan RGLS (Regulus Therapeutics Inc)|SYRS - Volume dodolan mangsa ngarep perusahaan|TBIO - Prakiraan pendapatan perusahaan|Volume dodolan sing dikarepake perusahaan traconpharma.com|UBX: Prakiraan volume dodolan
